Genentech Inc. Newsletter
-
Genentech preps for flu season with DTC program offering discounted Xofluza
17 Oct 2025 01:05 GMT
… its list price, per Genentech.
The program will fulfill … in seeking their medicines,” Genentech CEO Ashley Magargee said in … the announcement.
Genentech noted that it already offers … direct purchasing platform.
Indeed, Genentech said in this week’s …
-
Scott St. Germain, U.S. Army Veteran and Vice President at Genentech, Joins Dream Foundation Board
16 Oct 2025 02:05 GMT
… veteran and Vice President at Genentech, has joined the Board of … Harvard Business School before joining Genentech, a leading biotechnology company and … partner since 2007. While at Genentech, St. Germain has led multiple …
-
Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types
13 Oct 2025 05:34 GMT
… Berlin, Germany. The data underscore Genentech’s commitment to deliver transformative …
Overview of key presentations featuring Genentech medicines:
Medicine
Abstract title
Abstract … Important Safety Information.
About Genentech
Founded nearly 50 years ago …
-
<![CDATA[Rethinking Progressive MS Studies to Better Include Advanced Patients: Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath]]>
17 Oct 2025 02:18 GMT
… trial (NCT04035005) of ocrelizumab (Ocrevus; Genentech). Led by Gavin Giovannoni, MBBCh …
-
<![CDATA[In Its 50th Year, ESMO Comes to Berlin, a City Transformed]]>
17 Oct 2025 02:26 GMT
… of ctDNA-guided atezolizumab (Tecentriq; Genentech) vs placebo in MIBC, while …
-
Unintended Consequences: Human Growth Hormone and Protein-Misfolding Diseases: A Historical Perspective
17 Oct 2025 00:17 GMT
… ) brought its own challenges. The Genentech company began producing rhGH in …
-
Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight
16 Oct 2025 22:04 GMT
… , Novartis, Daiichi Sankyo, Genmab, AbbVie, Genentech (a Member of Roche), Bristol …
-
<![CDATA[Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib]]>
16 Oct 2025 20:43 GMT
… approved in 2024 inavolisib (Itovebi; Genentech) with palbociclib (Ibrance; Pfizer … East Hanover (NJ): Novartis; 2025.
Genentech, Inc. Inavolisib [package insert]. South … San Francisco (CA): Genentech; 2025.
AstraZeneca Pharmaceuticals LP. …
-
<![CDATA[Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab]]>
16 Oct 2025 20:43 GMT
… biosimilar to originator bevacizumab (Avastin; Genentech), exhibited noninferior efficacy to its …
-
<![CDATA[Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2]]>
16 Oct 2025 20:43 GMT
… trial (NCT04663347), and glofitamab (Columvi; Genentech/Roche), a CD20 × CD3 …
About
© 1995-2025